Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31836| Title: | Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution. | Austin Authors: | McEwan, Tim;Bhambra, Jaspreet;Liew, David F L ;Robinson, Philip C | Affiliation: | Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Herston, QLD 4029, Australia. University of Queensland School of Clinical Medicine, Faculty of Medicine, Herston, QLD 4029, Australia. Rheumatology Clinical Pharmacology and Therapeutics Department of Medicine, University of Melbourne, Parkville VIC 3052, Australia. |
Issue Date: | 2023 | Date: | 2022-12 | Publication information: | Seminars in Arthritis and Rheumatism 2022 | Abstract: | To identify reports of colchicine-induced neuropathy and myopathy and ascertain risk factors associated with this toxicity at commonly used doses. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31836 | DOI: | 10.1016/j.semarthrit.2022.152150 | ORCID: | Journal: | Seminars in Arthritis and Rheumatism | Start page: | 152150 | PubMed URL: | 36512928 | ISSN: | 1532-866X | Type: | Journal Article | Subjects: | Colchicine Creatine kinase Drug interactions Liver dysfunction Muscle Myopathy Nerve Neuropathy Renal dysfunction |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.